The demand for active pharmaceutical ingredients (APIs) is presently rising across the globe on account of the burgeoning pharmaceutical industry. This growth can primarily be attributed to the increasing expenditure on healthcare facilities, in confluence with the growing investments in the drug development sector. According to the global active pharmaceutical ingredients market reportby IMARC Group, the market reached a value of US$ 176.3 Billion in 2018. Looking forward, the global active pharmaceutical ingredients market size is further projected to reach US$ 247.2 Billion by 2024, at a CAGR of around 5.8% during 2019-2024.

According to the latest report by IMARC Group, titled “Global Analgesics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global analgesics market size reached US$ 44.3 Billion in 2018. Analgesics are a type of drugs designed to relieve or control pain. Most of these drugs act on the body’s peripheral and central nervous systems to reduce or block sensitivity to pain. However, some of the analgesics work by preventing the formation of certain chemicals in the body that mediate pain. These painkillers are prescription-only medicines that are used strictly under doctor’s instruction and recommendation. They are used to treat moderate to severe pain including backache, neck pain, pre-menstrual and...

According to the latest report by IMARC Group titled, “Generic Drugs Market Report: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the market reached a value of US$ 315 Billion in 2017. Looking forward, the market is expected to reach a value of US$ 474 Billion by 2023, exhibiting a CAGR of around 6.8% during 2018-2023.